Latin America and the Caribbean vs Peru: Proportion of the target population who received the final dose of
Latin America and the Caribbean
69.0%
in 2024
Peru
97.0%
in 2024
Latin America and the Caribbean rank
4th
Peru rank
3rd
Proportion of the target population who received the final dose of over time
- Latin America and the Caribbean
- Peru
How they compare
Peru currently reports 97.0% against 69.0% in Latin America and the Caribbean, a difference of 28.0%.
That makes Peru's figure about 1.4 times Latin America and the Caribbean's.
The two have swapped places 6 times across 14 shared years of data; in 2011 it was Peru ahead.
Latin America and the Caribbean ranks 4th and Peru ranks 3rd of 35 groups.
Across the 2 decades both report, Latin America and the Caribbean averaged higher in 1 and Peru in 1.
Head to head by decade
| Decade | Latin America and the Caribbean | Peru | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 43.3% | 40.4% | 2.9% | Latin America and the Caribbean |
| 2020s | 49.4% | 53.2% | 3.8% | Peru |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of the target population who received the final dose of, Latin America and the Caribbean or Peru?
- Peru, at 97.0% against 69.0% in Latin America and the Caribbean as of 2024.
- What is the difference in proportion of the target population who received the final dose of between Latin America and the Caribbean and Peru?
- 28.0%, with Peru ahead.
- How many years of comparable data are there for Latin America and the Caribbean and Peru?
- 14 years are reported by both, from 2011 to 2024.
- How do Latin America and the Caribbean and Peru rank globally for proportion of the target population who received the final dose of?
- Latin America and the Caribbean ranks 4th and Peru ranks 3rd of 35 groups.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Proportion of the target population who received the final dose of human papillomavirus (HPV) vaccine (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.